Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Gilead Sciences 7.803, Abbott Laboratories 12.593.
Gilead Sciences vs Abbott Laboratories Net Worth and Market Cap
Gilead Sciences (GILD) and Abbott Laboratories (ABT) are peers in Healthcare. Gilead Sciences reported revenue of $7.8B as of Q2 2026, compared with $12.6B for Abbott Laboratories. Abbott Laboratories leads on revenue.
Gilead Sciences's gross margin is 79.8% versus 58.0% for Abbott Laboratories. Gilead Sciences's net margin is -134.5% versus 7.4% for Abbott Laboratories.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Gilead Sciences, Abbott Laboratories.| Metric | Gilead Sciences | Abbott Laboratories |
|---|---|---|
| Market Cap | - | - |
| Revenue | $7.80B | $12.59B |
| Cost of Revenue | $1.58B | $5.29B |
| Gross Profit | $6.22B | $7.30B |
| Operating Income | $-10.39B | $1.78B |
| Net Income | $-10.50B | $928.00M |
| R&D Expense | $1.76B | $882.00M |
| Earnings Per Share | -$8.45 | $0.53 |
| Gross Margin | 79.8% | 58.0% |
| Operating Margin | -133.2% | 14.2% |
| Net Profit Margin | -134.5% | 7.4% |
| Free Cash Flow | $3.69B | $2.89B |
| Cumulative Free Cash Flow | $155.83B | $142.48B |
| Operating Cash Flow | $3.57B | $2.49B |
| Cash & Equivalents | $3.18B | $5.10B |